London: The diagnosed prevalent cases of human immunodeficiency virus (HIV) in the seven major markets (7MM*) are projected to increase from 2 million in 2023 to reach 2.18 million in 2033, according to an estimate by Data-analysis firm GlobalData.
Through a latest report GlobalData has projected that diagnosed prevalent HIV cases will increase at an annual growth rate (AGR) of 0.90 per cent from 2.00 million in 2023 to 2.18 million in 2033.
As per the projections, across the 7 major markets (US, France, Germany, Italy, Spain, the UK, and Japan) with approximately 1.46 million cases, the US will have the highest number of cases, whereas Japan will have the fewest diagnosed prevalent cases with approximately 34,400 cases.
“Diagnosed prevalent cases of HIV are expected to increase due to a combination of the increased diagnosis rate of HIV, the increased life expectancy of HIV-positive people due to anti-retroviral treatment (ART), and population dynamics in the 7MM,” Casey Freimuth, Senior Epidemiologist, GlobalData, elaborated.
“Future efforts to reduce the burden of HIV should involve increased attention on reducing transmission, either through PrEP or through the use of ART, in combination with education and increased access to testing,” Freimuth added.
